The Evolution of Ketamine in Severe Pediatric Traumatic Brain Injury, From Contraband to Promising Neuroprotectant?

Crit Care Med. 2023 May 1;51(5):677-680. doi: 10.1097/CCM.0000000000005826. Epub 2023 Apr 13.

Authors

Patrick M Kochanek¹, Jeremy R Herrmann², Thomas P Bleck³

Affiliations

¹ Department of Critical Care Medicine, Safar Center for Resuscitation Research, UPMC Children's Hospital of Pittsburgh, Pittsburgh, PA.
² Department of Critical Care Medicine, University of Pittsburgh School of Medicine, UPMC Children's Hospital of Pittsburgh, Pittsburgh, PA.
³ Ken and Ruth Davee Department of Neurology, Northwestern University, Northwestern University Feinberg School of Medicine, Chicago, IL.

PMID: 37052437
DOI: 10.1097/CCM.0000000000005826

No abstract available

Publication types

Research Support, Non-U.S. Gov't
Editorial
Research Support, N.I.H., Extramural
Comment

MeSH terms

Brain Injuries* / drug therapy
Brain Injuries, Traumatic* / drug therapy
Child
Humans
Ketamine* / therapeutic use
Neuroprotective Agents* / therapeutic use

Substances

Ketamine
Neuroprotective Agents

Grants and funding

T32 HD040686/HD/NICHD NIH HHS/United States